<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645475/" ref="ordinalpos=648&amp;ncbi_uid=1675279&amp;link_uid=PMC2645475" image-link="/pmc/articles/PMC2645475/figure/F1/" class="imagepopup">Figure 1. Classical TGF-β <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>.  From: Transforming growth factor-beta <span class="highlight" style="background-color:">signaling</span> in thoracic aortic aneurysm development: a paradox in pathogenesis. </a></div><br /><div class="p4l_captionBody">The classical profibrotic TGF-β signaling pathway is initiated upon binding of ligand to a homodimer of the type II TGF-β receptor (TGF-βRII) (<b>1</b>.). The type II receptor is autophosphorylated (<b>2.</b>), which then recruits and transphosphorylates a type I receptor (TGF-βRI) (<b>3.</b>). The activated type I receptor in turn phosphorylates and activates a receptor-Smad (R-Smad) (<b>4.</b>). The R-Smad then binds the common co-Smad (<b>5.</b>) and translocates to the nucleus (<b>6.</b>). Once in the nucleus, it binds transcriptional co-factors and forms an activated transcriptional complex capable of inducing transcription of profibrotic genes (<b>7.</b>).</div></div>